Annexon biosciences to present at the 40th annual j.p. morgan healthcare conference

Brisbane, calif., jan. 04, 2022 (globe newswire) -- annexon, inc. (nasdaq: annx), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that douglas love, esq., president & chief executive officer, will present at the 40th annual j.p. morgan healthcare conference on tuesday, january 11, 2022, at 3:45 p.m. et.
ANNX Ratings Summary
ANNX Quant Ranking